10602361001
Roche
Plasmin, human
from human plasma
Synonym(e):
Plasmin
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
Empfohlene Produkte
Biologische Quelle
human plasma
Qualitätsniveau
Assay
95% (electrophoresis)
Form
suspension
Spezifische Aktivität
~8 units/mg protein (At 25 °C with Chromozym PL as the substrate.)
Mol-Gew.
Mr ~85 kDa
Verpackung
pkg of 0.5 mL (5 U)
Hersteller/Markenname
Roche
Optimaler pH-Wert
8.9
Versandbedingung
wet ice
Allgemeine Beschreibung
Inhibitors: DFP, PMSF, TLCK, leupeptin, aprotinin, soybean trypsin inhibitor, α1-antitrypsin, α2-macroglobulin, anti-thrombin III heparin, APMSF, and α2-antiplasmin
Fibrinolysin
Spezifität
Serine endopeptidase that hydrolyzes peptide and ester bonds at the carboxylic side of Lys or Arg; more selective than trypsin.
Anwendung
Human plasmin has been used as an oligopeptide substrate in peptidase inhibition assays.
Biochem./physiol. Wirkung
Plasmin is a direct acting fibrinolytic enzyme present in blood. Its activity is independent of plasminogen presence during fibrinolysis. Plasmin is rapidly and irreversibly inhibited by α-2 antiplasmin.
Physikalische Form
Suspension in 3.2 M ammonium sulfate solution
Angaben zur Herstellung
Stabilizers: Human plasmin does not contain stabilizers.
Storage conditions (working solution): 2 to 8 °C
Diluted solution (pH 8.6) is stable at 2 to 8 °C for at least 1–2 weeks. For storage of dialyzed solution freezing in aliquots is recommended.
Storage conditions (working solution): 2 to 8 °C
Diluted solution (pH 8.6) is stable at 2 to 8 °C for at least 1–2 weeks. For storage of dialyzed solution freezing in aliquots is recommended.
Lagerung und Haltbarkeit
Store at 2 to 8 °C. (Recommended form for storage is ammonium sulfate suspension 3.2 M, pH 8.6.)
Sonstige Hinweise
For life science research only. Not for use in diagnostic procedures.
Haftungsausschluss
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
Signalwort
Danger
H-Sätze
Gefahreneinstufungen
Eye Dam. 1 - Skin Corr. 1B
Lagerklassenschlüssel
12 - Non Combustible Liquids
WGK
WGK 1
Flammpunkt (°F)
No data available
Flammpunkt (°C)
No data available
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Identification and partial characterization of a novel serpin from Eudiplozoon nipponicum (Monogenea, Polyopisthocotylea
Roudnicky P, et al.
Parasite (Paris, France) (2018)
A novel Kunitz protein with proposed dual function from Eudiplozoon nipponicum (Monogenea) impairs haemostasis and action of complement in vitro
Jedlikova L, et al.
International Journal For Parasitology (2019)
Jialu Liu et al.
NPJ Regenerative medicine, 7(1), 34-34 (2022-07-01)
The biomaterial fibrin is widely used as a clinical tissue sealant in surgery. In preclinical research, fibrin is also extensively studied as a carrier material for growth factor delivery. In these applications, premature fibrin degradation leads to recurrent bleeding, tissue
R D Shlansky-Goldberg et al.
Journal of thrombosis and haemostasis : JTH, 6(6), 944-950 (2008-04-04)
Hemodialysis (HD) grafts often fail because of stenosis at the venous anastomosis and thrombotic occlusion. Percutaneous management relies on thrombolysis with plasminogen activators, mechanical removal of thrombus, and angioplasty of the stenotic lesion. This report describes a phase I trial
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.